Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Evaluation Criteria”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Study completedNCT02699073
What this trial is testing

Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib

Who this might be right for
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 55
Not applicableStudy completedNCT02033837
What this trial is testing

Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT

Who this might be right for
Coronary Artery DiseaseCardiac CT
Kumamoto University 309
Not applicableStudy completedNCT07781319
What this trial is testing

Early Gastric Cancer in the Spanish EURECCA Registry

Who this might be right for
Early Gastric CancerGastric Adenocarcinoma
Corporacion Parc Tauli 600
Not applicableStudy completedNCT03520309
What this trial is testing

Clinical Criteria for the Evaluation of Caries Lesions Around Restorations in Primary Teeth (CARDEC-03)

Who this might be right for
Dental CariesSecondary Dental Caries
University of Sao Paulo 163
Early research (Phase 1)Study completedNCT02944396
What this trial is testing

Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 25
Large-scale testing (Phase 3)Looking for participantsNCT07225504
What this trial is testing

Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals 1,275
Not applicableStudy completedNCT03017313
What this trial is testing

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Ipsen 510
Not applicableLooking for participantsNCT06455332
What this trial is testing

Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University Hospital, Lille 200
Early research (Phase 1)Ended earlyNCT04349280
What this trial is testing

Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer

Who this might be right for
Neoplasms
GlaxoSmithKline 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT06434077
What this trial is testing

Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
S.LAB (SOLOWAYS) 60
Not applicableStudy completedNCT01163305
What this trial is testing

PET-CT and Circulating Tumor Cells in Colorectal Cancer

Who this might be right for
Colorectal CancerMetastasis
Chinese University of Hong Kong 84
Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Not applicableStudy completedNCT04337957
What this trial is testing

Elderly Patients With Renal Insufficiency: Reasons for Using the Geriatrician, Modalities and Results of the Geriatric Evaluation, Becoming at One Year

Who this might be right for
Secondary Evaluation CriteriaComorbidities and Coexisting ConditionsMotility Disorder
Centre Hospitalier Universitaire de Nīmes 100
Not applicableUnknownNCT03616951
What this trial is testing

Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CT

Who this might be right for
Renal Neoplasm With MetastasisResponse Evaluation Criteria in Solid Tumors
University of Aarhus 60
Testing effectiveness (Phase 2)UnknownNCT00290485
What this trial is testing

Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Maisonneuve-Rosemont Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02113800
What this trial is testing

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

Who this might be right for
Poorly Differentiated Malignant Neuroendocrine CarcinomaNeuroendocrine Carcinoma, Grade 3Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3+2 more
AIO-Studien-gGmbH
Early research (Phase 1)Looking for participantsNCT07238075
What this trial is testing

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
Advanced MalignancyAdvanced Solid CancersMetastatic Solid Tumors
Adcytherix SAS 290
40